However, the research findings indicated that there was no significant difference in the surface expression of PD-1 in CD4+ T cells between DLBCL patients and normal individuals in peripheral blood (P > 0.05), while there was a difference in LAG-3 expression (P < 0.05). The gene discussed is CD4; the disease is diffuse large B-cell lymphoma.